Physician

Amy Elizabeth Iwamaye, MD

According to 2025 Medicare claims, Amy Iwamaye, MD (NPI: 1255575130) practices endocrinology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Chester, PA. This provider's primary affiliated billing organization is SUBURBAN ENDOCRINOLOGY ASSOCIATES, PC (NPI: 1568551984; TIN: 20-1721011) and primary practice location at 19301-1610. Iwamaye is affiliated with the Delaware Valley ACO (ACO ID: A2024), participating under the MSSP model.

Iwamaye's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 251 traditional Medicare patients, billed 793 HCPCS/CPT codes, and received $57,810 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 509 prescription claims across 132 beneficiaries totaling $195,616 in drug costs, led by Ozempic (Semaglutide). DME data shows 49 claims. Open Payments data shows 24 records totaling $437. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $9,641 to $57,810. Similarly, Part D prescription costs have risen steadily, from $824 to $195,616. For DME billing, reported payments moved sharply higher in recent years, from $1,511 to $29,678.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	73	89	$9,641
2020	167	401	$27,593
2021	143	243	$19,660
2022	117	192	$15,016
2023	146	211	$19,248
2024	251	793	$57,810

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	28	$824
2016	N/R	N/R	N/R
2017	59	226	$57,668
2018	106	707	$218,102
2019	111	531	$180,864
2020	184	1,277	$514,398
2021	212	1,355	$583,497
2022	232	1,371	$549,331
2023	209	1,309	$546,922
2024	132	509	$195,616

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	31	$648
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	11	78	$7,728
2021	11	85	$9,700
2022	N/R	89	$15,219
2023	11	101	$18,300
2024	18	49	$26,284

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	72	72	$124
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	39	40	$106
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	101	189	$100
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	85	152	$64
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	108	163	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	42	1,764	$56,495
Rybelsus	Semaglutide	23	1,110	$32,666
Trulicity	Dulaglutide	19	538	$17,932
Jardiance	Empagliflozin	11	930	$17,004
Mounjaro	Tirzepatide	12	346	$12,117

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	18	49	$26,284

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	24	$437	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amy Elizabeth Iwamaye, MD?

Tedicare shows public-source Medicare data for Amy Elizabeth Iwamaye, MD (NPI 1255575130), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amy Elizabeth Iwamaye, MD have ACO affiliation data?

Amy Elizabeth Iwamaye, MD is shown with ACO affiliation data for Delaware Valley ACO (MSSP, ACO ID A2024).

What billing organization is linked to Amy Elizabeth Iwamaye, MD?

Amy Elizabeth Iwamaye, MD is linked to SUBURBAN ENDOCRINOLOGY ASSOCIATES, PC (billing NPI 1568551984) in the available physician profile data.

Does Amy Elizabeth Iwamaye, MD have Open Payments data?

Amy Elizabeth Iwamaye, MD has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.